# The Sponsor Assigns Test Products to Six Skin Areas According to a Concealed Randomization Schedule; Neither the Evaluating Physicians Nor the Participants Know Which Product is Applied to Which Site, Preventing Bias.

> **NCT07154004** · NA · COMPLETED · sponsor: **BEIJING YUANBEN INFORMATION CONSULTING CO., LTD** · enrollment: 30 (actual)

## Conditions studied

- No Protrusion
- No Open Wound
- No Severe Allergic Reaction
- No Scar
- No Tattoo
- No Significant Skin Defect

## Interventions

- **OTHER:** Test Serum 897222 210
- **OTHER:** Test Serum 897222 212
- **OTHER:** Test Serum 897250 39
- **OTHER:** Test Serum 897250 102D
- **OTHER:** Test Serum 774569 67

## Key facts

- **NCT ID:** NCT07154004
- **Lead sponsor:** BEIJING YUANBEN INFORMATION CONSULTING CO., LTD
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-12-21
- **Primary completion:** 2025-05-31
- **Final completion:** 2025-05-31
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2025-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07154004

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07154004, "The Sponsor Assigns Test Products to Six Skin Areas According to a Concealed Randomization Schedule; Neither the Evaluating Physicians Nor the Participants Know Which Product is Applied to Which Site, Preventing Bias.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07154004. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*